Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$370M |
| 2 |
Amazon
AMZN
|
+$349M |
| 3 |
Microsoft
MSFT
|
+$336M |
| 4 |
Meta Platforms (Facebook)
META
|
+$181M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$149M |
| 3 |
Waste Management
WM
|
+$122M |
| 4 |
McDonald's
MCD
|
+$113M |
| 5 |
Eli Lilly
LLY
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.15% |
| 2 | Healthcare | 14.17% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Communication Services | 11.59% |
| 5 | Industrials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Freedom Holding
FRHC
$9.35B
| $2.52M | ﹤0.01% |
38,600
-1,400
| -4% | -$74K |
|
|
TGI
1952
DELISTED
Triumph Group
TGI
| $2.52M | ﹤0.01% |
121,200
+2,100
| +2% | +$38.7K |
|
1953
Dillards
DDS
$9.59B
| $2.51M | ﹤0.01% |
13,900
-5,000
| -26% | -$645K |
|
1954
TFS Financial
TFSL
$4.93B
| $2.51M | ﹤0.01% |
123,700
-4,400
| -3% | -$91.5K |
|
1955
Matthews International
MATW
$722M
| $2.51M | ﹤0.01% |
69,796
+800
| +1% | +$31.9K |
|
|
MCFE
1956
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $2.51M | ﹤0.01% |
+89,500
| New | +$2.29M |
|
1957
OFG Bancorp
OFG
$2.26B
| $2.51M | ﹤0.01% |
113,300
-4,100
| -3% | -$97.4K |
|
1958
RLX Technology
RLX
$2.44B
| $2.51M | ﹤0.01% |
287,050
+69,500
| +32% | +$710K |
|
|
DFTX
1959
Definium Therapeutics
DFTX
$5.9B
| $2.5M | ﹤0.01% |
+47,767
| New | +$2.51M |
|
|
TRHC
1960
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.5M | ﹤0.01% |
49,900
-1,800
| -3% | -$80.6K |
|
1961
Seaboard Corp
SEB
$4.08B
| $2.48M | ﹤0.01% |
640
-18
| -3% | -$67.5K |
|
1962
BancFirst
BANF
$3.89B
| $2.47M | ﹤0.01% |
39,618
-1,500
| -4% | -$103K |
|
1963
Cytokinetics
CYTK
$10.2B
| $2.47M | ﹤0.01% |
124,800
-20,700
| -14% | -$486K |
|
1964
Huron Consulting
HURN
$2.47B
| $2.47M | ﹤0.01% |
50,200
-2,100
| -4% | -$113K |
|
1965
LeMaitre Vascular
LMAT
$1.87B
| $2.46M | ﹤0.01% |
40,400
+900
| +2% | +$47.8K |
|
|
DVAX
1966
DELISTED
Dynavax Technologies
DVAX
| $2.46M | ﹤0.01% |
249,678
+23,100
| +10% | +$210K |
|
1967
BRC Group Holdings
RILY
$303M
| $2.45M | ﹤0.01% |
32,500
+800
| +3% | +$56K |
|
|
SA
1968
Seabridge Gold
SA
$3.46B
| $2.45M | ﹤0.01% |
139,500
+15,600
| +13% | +$282K |
|
1969
Nuvation Bio
NUVB
$2.14B
| $2.44M | ﹤0.01% |
+262,600
| New | +$2.99M |
|
1970
Invesco Mortgage Capital
IVR
$805M
| $2.44M | ﹤0.01% |
62,611
+10,700
| +21% | +$405K |
|
1971
Dime Commercial Bancshares
DCOM
$1.82B
| $2.44M | ﹤0.01% |
72,602
-7,400
| -9% | -$249K |
|
1972
Artivion
AORT
$1.39B
| $2.44M | ﹤0.01% |
85,900
-2,900
| -3% | -$79K |
|
|
PLL
1973
DELISTED
Piedmont Lithium
PLL
| $2.44M | ﹤0.01% |
+31,200
| New | +$2.12M |
|
1974
Viper Energy
VNOM
$14.8B
| $2.44M | ﹤0.01% |
129,500
-10,000
| -7% | -$179K |
|
1975
Atara Biotherapeutics
ATRA
$76.7M
| $2.44M | ﹤0.01% |
6,268
-476
| -7% | -$170K |
|
Similar funds
Swiss National Bank's Q2 2021 Portfolio in Review
As of Q2 2021, Swiss National Bank held 2,687 positions worth $162B, up 8.1% from $150B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Swiss National Bank's Q2 2021 filing shows 205 new, 908 increased, 1,482 reduced and 45 closed positions. Its largest new stake was Lyft: 1,044,300 shares worth $63.2M. The largest sale was Alibaba, an estimated $1.07B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2021 buy was Lyft: 1,044,300 shares worth $63.2M.
- Swiss National Bank added most to Apple in Q2 2021, an estimated $370M increase.
- Swiss National Bank's biggest Q2 2021 reduction was Newmont, cutting an estimated $149M.
- Swiss National Bank fully exited Alibaba in Q2 2021, selling an estimated $1.07B.
- Swiss National Bank's ten largest holdings make up 25% of its $162B portfolio in Q2 2021.
- Swiss National Bank opened 205 new positions and closed 45 in Q2 2021.
- Swiss National Bank's portfolio value rose 8.1% quarter-over-quarter to $162B.
Based on Swiss National Bank's 13F filing for Q2 2021, filed 6 Aug 2021.